Home LiteratureArticle Details
PMID: 10878389 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 165 ·No. 2 ·2000-07-15 ·Pages 1102-10

Cameron MJ, Arreaza GA, Grattan M, Meagher C, Sharif S, Burdick MD, Strieter RM, Cook DN, Delovitch TL

Abstract

We investigated the biological role of CC chemokines in the Th1-mediated pathogenesis of spontaneous type I diabetes in nonobese diabetic (NOD) mice. Whereas an elevated ratio of macrophage inflammatory protein-1alpha (MIP-1alpha):MIP-1beta in the pancreas correlated with destructive insulitis and progression to diabetes in NOD mice, a decreased intrapancreatic MIP-1alpha:MIP-1beta ratio was observed in nonobese diabetes-resistant (NOR) mice. IL-4 treatment, which prevents diabetes in NOD mice by polarizing intraislet Th2 responses, decreased CCR5 expression in islets and potentiated a high ratio of MIP-1beta and monocyte chemotactic protein-1 (MCP-1): MIP-1alpha in the pancreas. Furthermore, NOD.MIP-1alpha-/- mice exhibited reduced destructive insulitis and were protected from diabetes. Neutralization of MIP-1alpha with specific Abs following transfer of diabetogenic T cells delayed the onset of diabetes in NOD.Scid recipients. These studies illustrate that the temporal expression of certain CC chemokines, particularly MIP-1alpha, and the CCR5 chemokine receptor in the pancreas is associated with the development of insulitis and spontaneous type I diabetes.

MeSH Terms
Adjuvants, Immunologic/therapeutic use Animals CCR5 Receptor Antagonists Cell Movement/immunology Chemokine CCL3 Chemokine CCL4 Chemokines, CC/biosynthesis,metabolism Diabetes Mellitus, Type 1/etiology,immunology,pathology,therapy Disease Progression Female Interleukin-4/therapeutic use Islets of Langerhans/immunology,metabolism,pathology Macrophage Inflammatory Proteins/deficiency,genetics,metabolism,physiology Mice Mice, Inbred C57BL Mice, Inbred NOD Mice, Knockout Mice, SCID Pancreas/immunology,metabolism,pathology RNA, Messenger/antagonists & inhibitors,biosynthesis Receptors, CCR5/biosynthesis,genetics Spleen/cytology,immunology,metabolism T-Lymphocyte Subsets/metabolism,pathology Th2 Cells/immunology,metabolism
Chemicals
Adjuvants, Immunologic CCR5 Receptor Antagonists Chemokine CCL3 Chemokine CCL4 Chemokines, CC Macrophage Inflammatory Proteins RNA, Messenger Receptors, CCR5 Interleukin-4
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Cameron M J
Autoimmunity/Diabetes Group, The John P. Robarts Research Institute, London, Ontario, Canada.
Arreaza G A
Grattan M
Meagher C
Sharif S
Burdick M D
Strieter R M
Cook D N
Delovitch T L
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2000-07-15
Pages
1102-10
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIGMS NIH HHS · GM20069 · United States
NHLBI NIH HHS · P50HL56402 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com